Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 0.81 | 0.97 | 0.93 | 2.25 |
Depreciation/ Depletion | 0.10 | 0.09 | 0.09 | 0.06 |
Non- Cash Items | -0.52 | -0.25 | -0.22 | -0.13 |
Changesin Working Capital | 0.26 | -0.44 | 1.47 | -1.71 |
Cashfrom Operating Activities | 0.64 | 0.38 | 2.27 | 0.47 |
Capital Expenditures | 0.00 | -0.03 | -0.31 | 0.00 |
Other Investing Cash Flow Items Total | -0.64 | -0.52 | -2.31 | 0.01 |
Cashfrom Investing Activities | -0.64 | -0.55 | -2.61 | 0.01 |
Net Changein Cash | 0.00 | -0.17 | -0.34 | 0.48 |
Cash Taxes Paid | -0.02 | -0.06 | 0.29 | 0.10 |
Emmessar Biotech & Nutrition Dividend Emmessar Biotech & Nutrition Bonus Emmessar Biotech & Nutrition News Emmessar Biotech & Nutrition AGM Emmessar Biotech & Nutrition Rights Emmessar Biotech & Nutrition Splits Emmessar Biotech & Nutrition Board Meetings Emmessar Biotech & Nutrition Key Metrics Emmessar Biotech & Nutrition Shareholdings Emmessar Biotech & Nutrition Profit Loss Emmessar Biotech & Nutrition Balance Sheet Emmessar Biotech & Nutrition Q1 Results Emmessar Biotech & Nutrition Q2 Results Emmessar Biotech & Nutrition Q3 Results Emmessar Biotech & Nutrition Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks